Ren Benjamin
Analyst
Citizens
Equibles does not estimate personal net worth.
About Ren Benjamin
Ren Benjamin is recorded as Analyst at Citizens. Ren Benjamin has spoken on 9 earnings calls and 3 other investor events across 8 companies, most recently for Kura Oncology, Inc. on October 13, 2026. Those appearances were for Iovance Biotherapeutics, Inc. (IOVA), Kura Oncology, Inc. (KURA), Bicara Therapeutics Inc. (BCAX), Zymeworks Inc. (ZYME), Allogene Therapeutics, Inc. (ALLO) and 3 other companies. The companies whose calls Ren Benjamin spoke on are classified in the Healthcare sector.
Ren Benjamin on recent calls
“I guess one for, or two for us, you know, can you talk a little bit about the non-responder animals and maybe what insights you may have learned as to why they aren't responding maybe outside of residual, you know, beta cell reserves, or if that's pretty much the only thing that you've been able to find regarding…”
“I guess two from us, what are your peak sales expectations for you, Pellerie, and kind of what is the potential timing of that? Are there any potential indications which could further expand this, Tam?”
“Let me echo my congratulations as well to the entire team. Maybe two quick ones for us.”
“Maybe just starting off with the interim analysis. Now that you've been able to sit on the data with the futility analysis, do you feel that this delta that you're seeing increases the chances of a successful interim mid-2027 versus, you know, what you were thinking when you first started the study?”
Affiliation history
-
Citizens
Analyst
Transcript header (unverified)
Current
Company network
Kura Oncology, Inc.
KURA
Biotechnology · Healthcare
2 appearances
Latest appearance 2026-10-13
View calls and events
Zymeworks Inc.
ZYME
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-09-28
View calls and events
BEONE MEDICINES LTD.
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-05-06
Recent activity
-
-
-
-
-
-
-
-
Earnings call
Q1 2026 Results
BEONE MEDICINES LTD.
-
-
-
-